CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Net Preferred Shares Issued and Repurchased (2019 - 2020)

Updated

CytoDyn (CYDY) reported Net Preferred Shares Issued and Repurchased of $882,000 for fiscal Q4 2020 (quarter ended May 31, 2020), down 71.4% from $3.08 million a year earlier and down 89.5% from the prior quarter.

Analysis

CytoDyn (CYDY) Net Preferred Shares Issued and Repurchased (2019 - 2020) Analysis & Trends

For FY2020 (ended May 31, 2020), CytoDyn posted Net Preferred Shares Issued and Repurchased of $13.41 million, up 334.8% from FY2019.

  • By fiscal year, Net Preferred Shares Issued and Repurchased came in at $3.08 million in FY2019.
  • Per Business Quant data, the three fiscal quarters before Q4 2020 came in at $8.38 million (Q3 2020), $2.4 million (Q2 2020) and $1.75 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CytoDyn 274.70 Mn 274.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2020 882,000.00
Feb 29, 2020 8.38 Mn
Nov 30, 2019 2.40 Mn
Aug 31, 2019 1.75 Mn
May 31, 2019 3.08 Mn
API Access

CytoDyn Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CYDY&period=max&api_key=YOUR_API_KEY